The Academy’s Bicentennial Capstone Event: Evening of May 8, 2017
"Challenge 2030"
Expected Attendees in addition to past recipients of the Blavatnik Awards for Young Scientists and Young Academy Members (aged 13-18)
(as of May 5, 2017)
*indicates Nobel Laureate
Asheesh Advani, Chief Executive Officer, JA Worldwide Rosalia Arteaga Serrano, President, Fidal Foundation; former President of Ecuador Holly Ash, Board Member, Aspen Brain Institute Richard Baum, Chief of Staff to the President, New York University Bradley Bell, Co-Founder and President, Bell-Phillip Television Production Gad Berdugo, Senior Advisor, Finance, Strategy and Corporate Development, EpiVax, Inc. Stacie Grossman Bloom, Assistant Vice President, Policy & Administration, NYU School of Medicine Lee Bollinger, President, Columbia University Karen Burke, Associate Clinical Professor, Mount Sinai Medical Center Kathryn Bushkin Calvin, President and CEO, UN Foundation Lewis C. Cantley, Meyer Director of the Sandra and Edward Meyer Cancer Center, Weill Cornell Medical College Brian Carter, Program Officer, Overdeck Family Foundation Robert Catell, Chairman, Advanced Energy Research & Technology Center, Stony Brook University; former President, National Grid U.S. *Martin Chalfie, Professor, Biological Sciences, Columbia University David Charbonneau, Professor of Astronomy, Harvard University & Blavatnik National Young Scientist Award Winner Nili Cohen, President, Israel Academy of Sciences and Humanities Ron Cohen, President and CEO, Acorda Therapeutics Cynthia Collins, Chief Executive Officer, Human Longevity, Inc. Brandie Conforti, Global Head of Development, JA Worldwide Elizabeth Cousens, Deputy CEO, UN Foundation Ceri Davies, Head of CNS Drug Discovery Unit, Takeda Pharmaceuticals Titia de Lange, Leon Hess Professor, Laboratory of Cell Biology and Genetics, The Rockefeller University Marlaina Deppe, President, Novo Arts Andrew ElBardissi, Partner, Deerfield Management Chad Evans, Executive Vice President, Council on Competitiveness Phillip Evans, Chief Communications Officer, Turner Enterprises Natasha Franck, Founder, EON *Jerome Friedman, Emeritus Professor of Physics, MIT Paul Gallay, President, Riverkeeper Alison Galvani, Burnett and Stender Families Professor of Epidemiology and Professor of Ecology and Evolutionary Biology, Yale University School of Public Health; Blavatnik Regional Young Scientist Award Winner Tamar Gendler, Dean of the Faculty of Arts and Sciences, Yale University Peter Goodwin, Chief Operating Officer and Treasurer, The Josiah Macy Jr. Foundation Daniel Goroff, Vice President and Program Director, The Alfred P. Sloan Foundation Nina Gray, Executive Director, NYU Neuroscience Institute Henry Greenberg, Special Lecturer, Epidemiology and Medicine, Columbia University Medical Center Nicholas Groombridge, Partner, Paul, Weiss, Rifkind, Wharton & Garrison LLP Drew Guff, Managing Director and Founding Partner, Siguler Guff and Company, LP Sam Hall, Principal, Apple Tree Partners Andrew Hamilton, President, New York University Rich Henning, Senior Vice President, Communications, SUEZ Rush Holt, President, American Association for the Advancement of Science Paul Horn, Senior Vice Provost for Research, NYU; former Senior Vice President and Executive Director of Research, IBM Alice S. Huang, Senior Faculty Associate in Biology, Caltech Hon. Jerry MacArthur Hultin, Senior Presidential Fellow, New York University; former Under Secretary of the United States Navy Simon Humphrey, Senior Manager, Corporate Responsibility, ARM Holdings Marnie Imhoff, Senior Vice President of Development, The Rockefeller University Lionel Ivashkiv, Chief Scientific Officer, Hospital for Special Surgery Thomas Jessell, Co-Director, Zuckerman Mind Brain Behavior Institute Charlie Kim, Chief Executive Officer, Next Jump Samantha Kappagoda, Co-Founder, Risk Economics, Inc.; RiskEcon® Lab for Decision Metrics, Courant Institute for Mathematical Sciences Robert Keller, President, National Grid Foundation Mehmood Khan, Vice Chairman & Chief Scientific Officer, PepsiCo Henrik Kingo, Founder and Director, Thanex Lise Kingo, Executive Director, UN Global Compact Martin Kohn, Chief Medical Scientist, Sentrian Niccole Kroll, Co-Founder, Après Seema Kumar, VP, Innovation, Global Health, Policy Communication, Johnson & Johnson Abraham Lackman, Senior Officer, Civic Affairs, The Simons Foundation Pablo Legorreta, Founder & CEO, Royalty Pharma Chuan Poh Lim, Chairman, A*Star | Peter Lupoff, Chief Investment Officer, Tiburon Capital Management Amina Mohammed, Deputy Secretary-General, United Nations Ishiyaku M. Mohammed, Centre Director and CEO, Centre for Policy Research and Development Solutions, Abuja David Mordecai, Co-Founder, Risk Economics, Inc.; RiskEcon® Lab for Decision Metrics, Courant Institute for Mathematical Sciences Narayana Murthy, Co-Founder and former Chairman, Infosys Technologies Bjorn Nilsson, President, IVA (The Royal Swedish Academy of Engineering Sciences) Indra Nooyi, Chairman and Chief Executive Officer, PepsiCo Maddie Orton, Arts Correspondent, NJTV News Hisashi Owada, President, International Court of Justice; former Japanese Ambassador to the United Nations Svante Pääbo, Director, Department of Evolutionary Genetics, Max Planck Institute for Evolutionary Anthropology Leif Pagrotsky, Consul General of Sweden in New York Kevin Parker, Managing Partner, Sustainable Insight Capital Management LLC Yitzhak Peterburg, Interim CEO and President, Teva Pharmaceutical Industries John Petralia, Chief Marketing Officer, Aligned Energy Gregory Petsko, Professor, Weill Cornell Medicine Thomas Pompidou, Founder and Partner, Marker LLC G. Michael Purdy, Executive Vice President for Research, Columbia University Michael Rape, K. Peter Hirth Chair of Cancer Biology & HHMI Investigator, University of California, Berkeley; Blavatnik National Young Scientist Award Winner *Venkatraman Ramakrishnan, President, Royal Society, UK Catherine Ricou, Senior Vice President, Engineering, Technology and Innovation Services, SUEZ Rory Riggs, Managing Partner, Balfour Partners LLC *Sir Richard Roberts, Chief Scientific Officer, New England Bio Labs Jack Rosen, Chief Executive Officer, Rosen Partners Ann Rosenberg, Head of Global SAP University Alliances and SAP Next-Gen Labs, SAP Ellis Rubinstein, President and CEO, The New York Academy of Sciences Joanna Rubinstein, President and CEO, World Childhood Foundation – USA Stephen Sands, Vice President, Investment Banking and Chairman, Global Health Group, Lazard John Sexton, President Emeritus, New York University John R. Seydel, Director of Sustainability, City of Atlanta Laura Turner Seydel, Chairperson, Captain Planet Foundation Rutherford Seydel, Partner, Davis, Pickren, Seydel & Sneed, LLP Konstantin Shakhnovich, Partner and Head of Systematic Market Making, Goldman Sachs Bill Sisson, Senior Director, Sustainability, United Technologies Corporation Tom Speechley, Partner, The Abraaj Group Kathleen Stern, Director, Global Science & Biomedical Policy, Takeda Pharmaceuticals Bruce Stillman, President, Cold Spring Harbor Laboratory Paul Stoffels, Chief Scientific Officer, Johnson & Johnson Davia Temin, President and CEO, Temin and Company Incorporated George Thibault, President, Josiah Macy Jr. Foundation Peter Thoren, Executive Vice President, Access Industries Ted Turner, Chairman, UN Foundation Rob van Leen, Chief Innovation Officer, Royal DSM Sunny Varkey, Group Chairman, GEMS Global; Founder, Varkey Foundation and GEMS Education Craig Venter, Founder, Chairman & CEO, JCVI Institute Hans Vestberg, Executive Vice President and President of Network and Technology, Verizon Jan Vilcek, Research Professor, NYU School of Medicine; President, Vilcek Foundation Marica Vilcek, Vice President & Co-Founder, Vilcek Foundation William Wachtel, Partner, Wachtel Missry LLP John Wagner, Senior Vice President, Head of Translational Research and Early Clinical, Takeda Pharmaceuticals Paul Walker, Technologist and Philanthropist *James and Liz Watson Gerald Weissman, Research Professor, NYU School of Medicine Lawrence Wennogle, Vice President, Drug Discovery, Intra-Cellular Therapies Morris Wo, Director, Business Development, Gaopeng Kathryn Wylde, President and CEO, Partnership for New York City Xing Jijun, Counselor of Science & Technology, The Consulate General of the People’s Republic of China in New York Ion Yadigaroglu, Partner, Capricorn LLC Mohammad A. Zaidi, Former Executive Vice President and Chief Technology Officer, Alcoa Inc. Michael Zigman, President and CEO, NYC FIRST Nancy Zimpher, Chancellor, State University of New York |